No Causal Link Found for Aluminum-Adjuvanted Vaccines, Serious Health Outcomes
via HealthDayTHURSDAY, May 7, 2026 -- No causal association appears to exist between aluminum-adjuvanted vaccines and serious or long-term health outcomes, according to research published online May 6 in The BMJ.
Pamela Doyon-Plourde, from the Public Health Agency of Canada in Ottawa, and colleagues conducted a systematic review of human evidence on potential health effects of aluminum-adjuvanted vaccines. Fifty-nine studies were included in the review: 37 case series, 11 randomized controlled trials, nine cohort studies, and two ecological studies.
The researchers consistently found no association between aluminum-adjuvanted vaccines and serious or long-term health outcomes, including asthma, autism spectrum disorder, or other chronic conditions, based on high-quality evidence from randomized controlled trials and large cohorts. With respect to macrophagic myofasciitis, studies were generally small and methodologically limited, with no credible evidence of a causal association. After diphtheria-tetanus-pertussis vaccines, localized persistent nodules or granulomas were observed infrequently, consistent with delayed type hypersensitivity. High-certainty randomized controlled trials revealed no consistent increase in risk with aluminum-adjuvanted formulations for common adverse events such as headache and myalgia. When observed, differences were small and mainly mild to moderate in severity. The studies were often methodologically limited, with serious or critical risk for bias for most case series and ecological studies.
"These findings are consistent with the broader postlicensure safety evidence base, which supports continued use of aluminum-adjuvanted vaccines in immunization programs," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-08 02:39
Read more
- Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Prevalence of Selected Complementary Health Approaches High in Seniors
- Stress, Androgens Shape Pubescent Development Timing in Girls
- Denecimig (Mim8) Significantly Reduced Annualised Bleeding Rate in People with Hemophilia A, Regardless of Inhibitor Status, in Phase 3 Data Published in NEJM
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions